Abstract:Transforming growth factor β (TGF-β) superfamily signaling pathways are ubiquitous and essential for several cellular and physiological processes. The overexpression of TGF-β results in excessive fibrosis in multiple human disorders. Among them, stiff skin syndrome (SSS) is an ultrarare and untreatable condition characterized by the progressive thickening and hardening of the dermis, and acquired joint limitations. SSS is distinct in a widespread form, caused by recurrent germline variants of FBN1 encoding a key molecule of the TGF-β signaling, and a segmental form with unknown molecular basis. Here, we report a 12-year-old female with segmental SSS, affecting the right upper limb with acquired thickening of the dermis evident at the magnetic resonance imaging, and progressive limitation of the elbow and shoulder. To better explore the molecular and cellular mechanisms that drive segmental SSS, several functional studies on patient's fibroblasts were employed. We hypothesized an impairment of TGF-β signaling and, consequently, a dysregulation of the associated downstream signaling. Lesional fibroblast studies showed a higher phosphorylation level of extracellular signal-regulated kinase 1/2 (ERK1/2), increased levels of nuclear factor-kB (NFkB), and a nuclear accumulation of phosphorylated Smad2 via Western blot and microscopy analyses. Quantitative PCR expression analysis of genes encoding key extracellular matrix proteins revealed increased levels of COL1A1, COL3A1, AGT, LTBP and ITGB1, while zymography assay reported a reduced metalloproteinase 2 enzymatic activity. In vitro exposure of patient's fibroblasts to losartan led to the partial restoration of normal transforming growth factor β (TGF-β) marker protein levels. Taken together, these data demonstrate that in our patient, segmental SSS is characterized by the overactivation of multiple TGF-β signaling pathways, which likely results in altered extracellular matrix composition and fibroblast homeostasis. Our results for the first time reported that aberrant TGF-β signaling may drive the pathogenesis of segmental SSS and might open the way to novel therapeutic approaches.

New clinical classification of stiff skin syndrome

Classical Disease-Specific Autoantibodies In Systemic Sclerosis: Clinical Features, Gene Susceptibility, And Disease Stratification

Stiff Skin Syndrome: Clinical Exploration, Pathophysiology and Therapeutic Advances in a Rare Connective Tissue Disease

Childhood Onset Progressive Skin Fibrosis and Joint Immobility

Adult-Onset Still Disease Presenting With Dermatomyositis-Like Persistent Pruritic Lesions

A case report of integrating Chinese and Western medicine: A new era in the treatment of stiff person syndrome

Phenotypes of patients with systemic sclerosis in the Chinese Han population: a cluster analysis

Ultrasound Assessment of Skin Thickness and Stiffness: the Correlation with Histology and Clinical Score in Systemic Sclerosis

Cutaneous and Systemic Psoriasis: Classifications and Classification for the Distinction

Clinical features, electrophysiological characteristics and treatment response in eight cases with stiff-person syndrome

Mutations in fibrillin-1 cause congenital scleroderma: stiff skin syndrome

Clinical stratification of 1318 Primary Sjögren's Syndrome patients

A stretchable hardness sensor for systemic sclerosis diagnosis

Pro-Fibrotic Phenotype in a Patient with Segmental Stiff Skin Syndrome via TGF-β Signaling Overactivation

Systemic Sclerosis Sine Scleroderma: A Time of Reappraisal

The Value of Shear Wave Elastography in Diagnosis and Assessment of Systemic Sclerosis.

The diagnostic value and clinical relevance of high frequency ultrasound and shear wave elastography in systemic sclerosis: an observational monocentric study

[Expression and distribution of type I, III and V collagens in skin lesions from patients with systemic sclerosis]

Evaluating Skin Involvement in Systemic Sclerosis Using High-Frequency Ultrasound and Virtual Touch Tissue Imaging

Identification of a novel intronic variant of ATP6V0A2 in a Han-Chinese family with cutis laxa

Skin imaging in systemic sclerosis